Search
  • Site Search
  • News
  • Product
  • Zhejiang Medical Technology Development Co., Ltd.

    2020 year
    10
    20 day
    Winhealth Pharma Group helps make 12th Chinese Pharmacist Conference a complete success

    On October 16th, 2020, the 12th Chinese Pharmacist Conference, which was sponsored by the Chinese Pharmacists Association and the Expert Committee for Rational Drug Use of the National Health Commission of the People's Republic of China and was supported by Hongkong Winhealth Pharma Group Co., Ltd, was held in Beijing. Featuring the theme of 'Ability Creates Value', the conference discussed the pharmaceutical development and the pharmacist team construction from multiple perspectives.

     

    Ability creates value | Winhealth Pharma Group helps make 12th Chinese Pharmacist Conference a compl


    President Xi Jinping points out that health is an inevitable requirement for promoting people's all-round development, a basic condition for economic and social development, an important symbol of national well-being and prosperity, and a common pursuit of the broad masses of the people.

     

    Pharmacists, as an important part of a medical team, play an important role in the Healthy China strategy, which was discussed in the conference in order to strengthen the construction of the pharmacist team, fully reflect the value of pharmacists and promote rational drug use.

     

    The 12th Chinese Pharmacist Conference set up a main forum covering such topics as advantages of traditional Chinese medicine in treating diseases, the 'Belt and Road' for innovative drugs, applications and practice of pharmacist competency evaluation standards, and rational drug use, and set up corresponding sub-forums covering such topics as therapeutic drug monitoring, home pharmacy, clinical trial drug management, medication for rare diseases, drug treatment management, and construction of oncological pharmacist teams.

     

    Professor Song Hongmei acted as the chairman of the sub-forum on medication for rare diseases. Mr. Wang Wei, board chairman/founder/CEO of Hongkong Winhealth Pharma Group Co., Ltd., acted as the vice chairman of the Committee for Rational Drug Use for Rare Diseases, presided over the sub-forum on medication for rare diseases featuring the theme of 'Science, Technology, Promotion and Accessibility'.

     

    Ability creates value | Winhealth Pharma Group helps make 12th Chinese Pharmacist Conference a compl

    Ms. Song Hongmei, Pediatric Director of Union Hospital

     


    Ability creates value | Winhealth Pharma Group helps make 12th Chinese Pharmacist Conference a compl

    Mr. Wang Wei, vice chairman of Committee for Rational Drug Use for Rare Diseases

     

    At the conference, Professor Yang Li presented 'Current Situation of Diagnosis and Treatment of Rare Diseases in China and Recommended Research by International Experience', Professor Zou Chaochun presented 'Drug Treatment for Mucopolysaccharidosis', Professor Zhang Yuqin presented 'Progress of Diagnosis and Treatment of Spinal Muscle Atrophy', and a number of experts discussed a series of hot topics such as the development status and accessibility of drugs for rare diseases in China and the affordability of drugs for rare diseases, aiming at promoting the development of drugs for rare diseases in China.

     

    Ability creates value | Winhealth Pharma Group helps make 12th Chinese Pharmacist Conference a compl



    Ability creates value | Winhealth Pharma Group helps make 12th Chinese Pharmacist Conference a compl


    In order to promote the development of diagnosis and treatment of rare diseases and improve the quality of life of rare disease patients, Winhealth Pharma Group established Boao Lecheng Winhealth Clinical Medical Center for Rare Diseases in Hainan, aiming to allow global advanced drugs to provide domestic patients with timely treatment and solutions through the policy advantages of Boao Pilot Zone.

     

    It is the responsibility of pharmaceutical enterprises to develop undertakings of rare diseases and build a bridge connecting health and care. Let's make joint efforts to improve the diagnosis and treatment of rare diseases, benefit patients with rare diseases and their families, and develop undertakings of rare diseases!

     

     

    This conference is not only an academic gathering of Chinese pharmacists, but also a kind of spiritual and cultural inheritance. Helping the development of Chinese pharmacists means supporting the development of our motherland. Pharmacists not only take the responsibility for life, but also shoulder the responsibility for developing a Healthy China, which is not only inheritance, but also persistence. Winhealth Pharma Group will make unremitting efforts to meet more unmet needs of patients!

     

    About BO’AO WINHEALTH RARE DISEASE MEDICAL CENTER

     

    BO’AO WINHEALTH RARE DISEASE MEDICAL CENTER/BO’AO RARE DISEASE MEDICAL CENTER was jointly established on April 10, 2020 in BO’AO Lecheng international medical tourism pilot zone in the province of Hainan in China, by Win Health Investment (HK) Limited., Le Cheng Administration, Ruida Medicell International Medical Center. 

     

    Our mission is to keep pace with the latest development of the world to introduce the most advanced rare disease medical products into Chinese market, bringing unprecedented hope to patients with rare disease in China and neighboring countries and regions. We are committed to establishing the most comprehensive and advanced rare disease clinical medical center with the most advanced diagnosis and treatment services in China, Southeast Asia and other surrounding areas.

     

    About Winhealth Pharma

     

    Hong Kong Winhealth Pharma Group is an innovative Hong Kong-headquartered and China-focused pharmaceutical company, is committed to filling the huge medical demand gap of Greater China market by introducing and commercializing the patents and owns Established Pharmaceutical Division (EPD) and rare diseases-orientated Innovative Therapeutics Division (ITD). The former covers brand-name drugs in five fields: respiratory diseases and anti-infection, cardiovascular diseases, digestion and liver diseases, dermatology and cosmetic medicine, and urinary system diseases. Winhealth Pharma provides integrated service of local research and development, registration and commercialization for the internationally renowned pharmaceutical enterprises, and has become one of well-known CDCOs (contract development and commercialization organizations) in China, and the clients include several transnational pharmaceutical enterprises listed in the world’s top 500 enterprises. Headquartered in Hong Kong, Winhealth Pharma also establishes the operating centers and offices in Hangzhou, Shanghai, Beijing, Guangzhou, Hainan, Tokyo and Munich. Visit http://www.winhealth.hk for more information.

     


    3rd Floor, Winhealth Industrial Park, No. 272 Huancheng East Road, Xiacheng District, Hangzhou, Zhejiang, China
    BD@winhealth.Hk (overseas)
    0571-8718 6358    4008393773 ( Product Hotline )
    Copyright ©2019 - 2024 Zhejiang Medical Technology Development Co., Ltd.